miR-34a: a new player in the regulation of T cell function by modulation of NF-κB signaling.


Journal

Cell death & disease
ISSN: 2041-4889
Titre abrégé: Cell Death Dis
Pays: England
ID NLM: 101524092

Informations de publication

Date de publication:
18 01 2019
Historique:
received: 22 10 2018
accepted: 18 12 2018
revised: 13 12 2018
entrez: 6 2 2019
pubmed: 6 2 2019
medline: 31 3 2020
Statut: epublish

Résumé

NF-κB functions as modulator of T cell receptor-mediated signaling and transcriptional regulator of miR-34a. Our in silico analysis revealed that miR-34a impacts the NF-κB signalosome with miR-34a binding sites in 14 key members of the NF-κB signaling pathway. Functional analysis identified five target genes of miR-34a including PLCG1, CD3E, PIK3CB, TAB2, and NFΚBIA. Overexpression of miR-34a in CD4

Identifiants

pubmed: 30718475
doi: 10.1038/s41419-018-1295-1
pii: 10.1038/s41419-018-1295-1
pmc: PMC6362007
doi:

Substances chimiques

Adaptor Proteins, Signal Transducing 0
CD3 Complex 0
CD3E protein, human 0
MIRN34 microRNA, human 0
MicroRNAs 0
NF-kappa B 0
NFKBIA protein, human 0
TAB2 protein, human 0
NF-KappaB Inhibitor alpha 139874-52-5
Class I Phosphatidylinositol 3-Kinases EC 2.7.1.137
PIK3CB protein, human EC 2.7.1.137
PLCG1 protein, human EC 3.1.4.11
Phospholipase C gamma EC 3.1.4.3

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

46

Références

Semin Immunol. 2009 Apr;21(2):84-91
pubmed: 19298946
Nat Methods. 2015 Aug;12(8):697
pubmed: 26226356
Trends Immunol. 2013 Jun;34(6):269-81
pubmed: 23474202
Cell Stem Cell. 2010 Jul 2;7(1):36-41
pubmed: 20621048
Mamm Genome. 2002 Mar;13(3):169-72
pubmed: 11919689
Clin Immunol. 2007 Oct;125(1):5-15
pubmed: 17692570
Science. 2008 Aug 22;321(5892):1081-4
pubmed: 18719282
Blood. 2017 Mar 2;129(9):1071-1081
pubmed: 28115366
Nat Genet. 2015 Nov;47(11):1304-15
pubmed: 26437031
J Exp Med. 2012 Aug 27;209(9):1655-70
pubmed: 22891274
Blood. 2016 Sep 15;128(11):1490-502
pubmed: 27369867
Cold Spring Harb Perspect Biol. 2010 May;2(5):a000182
pubmed: 20452952
Tumour Biol. 2016 Aug;37(8):10177-85
pubmed: 26831660
Oncotarget. 2016 Jun 7;7(23):34288-99
pubmed: 27144431
J Immunol. 2015 Feb 15;194(4):1514-22
pubmed: 25582858
Blood. 1998 Aug 15;92(4):1334-41
pubmed: 9694722
J Exp Med. 2008 Sep 1;205(9):2005-17
pubmed: 18725527
J Immunol. 2001 May 1;166(9):5654-64
pubmed: 11313406
BMC Mol Biol. 2012 Jan 31;13:4
pubmed: 22292433
Am J Hum Genet. 2016 Aug 4;99(2):392-406
pubmed: 27426733
Biochemistry. 2017 Aug 1;56(30):3945-3961
pubmed: 28671821
Eur J Immunol. 2014 Jun;44(6):1870-2
pubmed: 24599783
Nat Immunol. 2005 Nov;6(11):1087-95
pubmed: 16186825
Oncotarget. 2015 Apr 20;6(11):8474-90
pubmed: 25893379
J Biol Chem. 2007 Jun 8;282(23):16776-82
pubmed: 17449468
Genes Dev. 1992 Oct;6(10):1899-913
pubmed: 1340770
J Immunol. 2004 Jul 1;173(1):33-41
pubmed: 15210756
Nat Methods. 2011 Sep 04;8(10):841-3
pubmed: 21892151
Nucleic Acids Res. 1989 Aug 11;17(15):6419
pubmed: 2771659
Mol Cell Biol. 2003 Feb;23(4):1231-8
pubmed: 12556483
Trends Immunol. 2011 Aug;32(8):358-63
pubmed: 21733754
JAMA. 2011 Jan 5;305(1):59-67
pubmed: 21205967
J Clin Invest. 2004 Nov;114(10):1512-7
pubmed: 15546002
Mol Cancer. 2014 Aug 30;13:202
pubmed: 25175044
J Clin Invest. 2002 Feb;109(3):301-9
pubmed: 11827988
Oncotarget. 2014 Oct 15;5(19):9484-97
pubmed: 25344866
EMBO J. 2004 Jun 16;23(12):2348-57
pubmed: 15152191
Nat Rev Mol Cell Biol. 2010 Apr;11(4):252-63
pubmed: 20216554
Immunology. 2012 Apr;135(4):261-7
pubmed: 22182461
J Exp Med. 2005 Feb 21;201(4):517-22
pubmed: 15728235
RNA Biol. 2018;15(6):819-825
pubmed: 29749304
J Exp Med. 2004 Sep 6;200(5):559-68
pubmed: 15337789
RNA Biol. 2007 Jun;4(2):76-84
pubmed: 17637574
Immunity. 2010 Oct 29;33(4):607-19
pubmed: 20888269
Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):11259-63
pubmed: 7479976
Nat Protoc. 2014 Apr;9(4):950-66
pubmed: 24675735
RNA. 2003 Mar;9(3):277-9
pubmed: 12592000
Immunity. 2005 Apr;22(4):479-91
pubmed: 15845452
J Immunol. 2007 Sep 15;179(6):3689-98
pubmed: 17785805
Nat Immunol. 2012 Jan 19;13(2):121-8
pubmed: 22261968

Auteurs

Martin Hart (M)

Institute of Human Genetics, Saarland University, 66421, Homburg, Germany. martin.hart@uks.eu.

Barbara Walch-Rückheim (B)

Institute of Virology and Center of Human and Molecular Biology, Saarland University Medical School, 66421, Homburg, Germany.

Kim S Friedmann (KS)

Biophysics, Center for Integrative Physiology and Molecular Medicine, School of Medicine, Saarland University, 66421, Homburg, Germany.

Stefanie Rheinheimer (S)

Institute of Human Genetics, Saarland University, 66421, Homburg, Germany.

Tanja Tänzer (T)

Institute of Virology and Center of Human and Molecular Biology, Saarland University Medical School, 66421, Homburg, Germany.

Birgit Glombitza (B)

Institute of Virology and Center of Human and Molecular Biology, Saarland University Medical School, 66421, Homburg, Germany.

Martina Sester (M)

Department of Transplant and Infection Immunology, Saarland University, 66421, Homburg, Germany.

Hans-Peter Lenhof (HP)

Center for Bioinformatics, Saarland University, 66123, Saarbrücken, Germany.

Markus Hoth (M)

Biophysics, Center for Integrative Physiology and Molecular Medicine, School of Medicine, Saarland University, 66421, Homburg, Germany.

Eva C Schwarz (EC)

Biophysics, Center for Integrative Physiology and Molecular Medicine, School of Medicine, Saarland University, 66421, Homburg, Germany.

Andreas Keller (A)

Saarland University, 66123, Saarbrücken, Germany.

Eckart Meese (E)

Institute of Human Genetics, Saarland University, 66421, Homburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH